Decile Access: Chaanakya Capital
Investing in the future of how we age, heal and thrive - NeuroTech!
Current Deals
Past Portfolio
Blurred Company name
You need to be logged in to see the company description.
Blurred Company name
You need to be logged in to see the company description.
Blurred Company name
You need to be logged in to see the company description.
Blurred Company name
You need to be logged in to see the company description.
Investment Terms
Frequently Asked Questions
Overview
We're focusing on NeuroTech and Neuro-focused Medtech for this fund. For the kind of demand for non-invasive and/or non-pharmaceutical solutions to chronic pain, stroke/paralysis, brain diseases and disorders (Alzheimer's, ADHD, Autism, Parkinson's, etc) the VC funding is underpenetrated (esp, at pre-seed stage). While most VCs don't have the deep technical expertise to assess the tech, we do! See our elevator pitch deck https://pitch.com/v/neurotech-elevator-pitch-ab7wsn and ask for the detailed NeuroTech segment analysis.
Quick Actions
Venture capital investing involves substantial risk, including risk of loss of all capital invested. Achievement of investment objectives cannot be guaranteed. Past performance does not guarantee future results. To see additional risk factors and considerations, please see Risk Factors and Investment Considerations.
No content hosted on this website is an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are made only to accredited investors pursuant to the formal offering documents, which describe the terms and other important information that must be carefully considered before an investment is made. We require verification of accreditation for all investors.
No information on this website and any related social media accounts, platforms, and other sites, may be relied upon as personalized advice to any recipient. These materials are provided for informational purposes only. Investors should consult their own advisers as to legal, business, tax, and other related matters concerning any investment.
Certain information herein constitutes "forward-looking statements" and you should not place undue reliance on these forward-looking statements.
